Location History:
- Bridgewater, NJ (US) (2012)
- Succasunna, NJ (US) (2013 - 2017)
Company Filing History:
Years Active: 2012-2017
Title: David Stefany: Innovator in Pharmaceutical Chemistry
Introduction
David Stefany is a notable inventor based in Succasunna, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate H3 receptors. With a total of 5 patents to his name, Stefany's work is paving the way for advancements in the treatment of various diseases.
Latest Patents
Among his latest patents is the invention titled "Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof." This patent discloses a series of substituted N-heteroaryl spirolactam bipyrrolidines, which are useful as pharmaceutical agents, especially in treating diseases associated with the central nervous system. The compounds are designed to act as modulators of H3 receptors, providing a therapeutic avenue for various conditions.
Another significant patent is "Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof." Similar to his previous work, this patent focuses on a series of substituted N-heteroaryl bipyrrolidine carboxamides that also serve as modulators of H3 receptors. This innovation further emphasizes the potential of these compounds in addressing central nervous system-related diseases.
Career Highlights
David Stefany is currently employed at Sanofi, a global leader in the pharmaceutical industry. His role involves extensive research and development, contributing to the advancement of innovative therapeutic solutions. His expertise in pharmaceutical chemistry has positioned him as a key player in the field.
Collaborations
Stefany has collaborated with notable colleagues, including Zhongli Gao and Daniel Hall. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in pharmaceutical chemistry.
Conclusion
David Stefany's contributions to the field of pharmaceutical chemistry are noteworthy, with a focus on developing innovative compounds for treating central nervous system diseases. His work at Sanofi and his collaborations with esteemed colleagues further highlight his commitment to advancing medical science.